Intracellular nicotinamide phosphoribosyltransferase protects against hepatocyte apoptosis and is down-regulated in nonalcoholic fatty liver disease

Journal of Clinical Endocrinology and Metabolism

Volumn 95, Issue 6, 2010, Pages 3039-3047

  Dahl, Tuva B ^a   Haukeland, John Willy ^c   Yndestad, Arne ^a   Ranheim, Trine ^a   Gladhaug, Ivar P ^a   Damås, Jan K ^a   Haaland, Terese ^b   Løberg, Else Marit ^b   Arntsen, Borghild ^d   Birkeland, Kåre ^a   Bjøro, Kristian ^c   Ulven, Stine M ^d,e   Konopski, Zbigniew ^c   Nebb, Hilde I ^d   Aukrust, Pål ^a   Halvorsen, Bente ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^c AKER UNIVERSITY HOSPITAL   (Norway)

^d UNIVERSITY OF OSLO   (Norway)

^e OSLO METROPOLITAN UNIVERSITY   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; NICOTINAMIDE ADENINE DINUCLEOTIDE; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; ANTIDIABETIC AGENT; INSULIN; SMALL INTERFERING RNA;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL SURVIVAL; CONTROLLED STUDY; ENZYME SYNTHESIS; FEMALE; GLUCOSE METABOLISM; HUMAN; HUMAN CELL; LIPID METABOLISM; LIVER CELL; MAJOR CLINICAL STUDY; MALE; MOUSE; NONALCOHOLIC FATTY LIVER; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; STEATOSIS; AGED; ANIMAL; CELL CULTURE; CELL LINE; DOWN REGULATION; ENZYMOLOGY; FATTY LIVER; GENETIC TRANSFECTION; LIVER MITOCHONDRION; METABOLISM; MIDDLE AGED; PATHOLOGY; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADULT; AGED; ANIMALS; APOPTOSIS; CELL LINE; CELLS, CULTURED; DOWN-REGULATION; FATTY LIVER; FEMALE; GLUCOSE; HEPATOCYTES; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; MALE; MICE; MIDDLE AGED; MITOCHONDRIA, LIVER; NAD; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; PPAR ALPHA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, SMALL INTERFERING; TRANSFECTION;

EID: 77954502566     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2009-2148     Document Type: Article

References (40)

1. Björnsson E, Angulo P 2007 Non-alcoholic fatty liver disease. Scand J Gastroenterol 42:1023-1030
2. Day CP, James OF 1998 Steatohepatitis: a tale of two "hits?" Gastroenterology 114:842-845
3. Marchesini G, Bugianesi E, Forlani G, Cerrelli F, Lenzi M, Manini R, Natale S, Vanni E, Villanova N, Melchionda N, Rizzetto M 2003 Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome. Hepatology 37:917-923
4. Samal B, Sun Y, Stearns G, Xie C, Suggs S, McNiece I 1994 Cloning and characterization of the cDNA encoding a novel human pre-Bcell colony-enhancing factor. Mol Cell Biol 14:1431-1437
5. Fukuhara A, Matsuda M, Nishizawa M, Segawa K, Tanaka M, Kishimoto K, Matsuki Y, Murakami M, Ichisaka T, Murakami H, Watanabe E, Takagi T, Akiyoshi M, Ohtsubo T, Kihara S, Yamashita S, Makishima M, Funahashi T, Yamanaka S, Hiramatsu R, Matsuzawa Y, Shimomura I 2005 Visfatin: a protein secreted by visceral fat that mimics the effects of insulin. Science 307:426-430 (Pubitemid 40139988)
6. Revollo JR, Grimm AA, Imai S 2004 The NAD biosynthesis pathway mediated by nicotinamide phosphoribosyltransferase regulates Sir2 activity in mammalian cells. J Biol Chem 279:50754-50763
7. + biosynthetic enzyme. Nat Struct Mol Biol 13:661-662
8. Yang H, Lavu S, Sinclair DA 2006 Nampt/PBEF/Visfatin: a regulator of mammalian health and longevity? Exp Gerontol 41:718-726
9. Sommer G, Garten A, Petzold S, Beck-Sickinger AG, Bluher M, Stumvoll M, Fasshauer M 2008 Visfatin/PBEF/Nampt: structure, regulation and potential function of a novel adipokine. Clin Sci (Lond) 115:13-23
10. Dahl TB, Yndestad A, Skjelland M, Øie E, Dahl A, Michelsen A, Damås JK, Tunheim SH, Ueland T, Smith C, Bendz B, Tonstad S, Gullestad L, Frøland SS, Krohg-Sørensen K, Russell D, Aukrust P, Halvorsen B 2007 Increased expression of visfatin in macrophages of human unstable carotid and coronary atherosclerosis: possible role in inflammation and plaque destabilization. Circulation 115:972-980
11. Rasouli N, Kern PA 2008 Adipocytokines and the metabolic complications of obesity. J Clin Endocrinol Metab 93(Suppl 1):S64-S73
12. Imai S 2009 Nicotinamide phosphoribosyltransferase (Nampt): a link between NAD biology, metabolism, and diseases. Curr Pharm Des 15:20-28
13. Luk T, Malam Z, Marshall JC 2008 Pre-B cell colony-enhancing factor (PBEF)/visfatin: a novel mediator of innate immunity. J Leukoc Biol 83:804-816
14. Jia SH, Li Y, Parodo J, Kapus A, Fan L, Rotstein OD, Marshall JC 2004 Pre-B cell colony-enhancing factor inhibits neutrophil apoptosis in experimental inflammation and clinical sepsis. J Clin Invest 113:1318-1327
15. Haukeland JW, Damås JK, Konopski Z, Løberg EM, Haaland T, Goverud I, Torjesen PA, Birkeland K, Bjøro K, Aukrust P 2006 Systemic inflammation in nonalcoholic fatty liver disease is characterized by elevated levels of CCL2. J Hepatol 44:1167-1174
16. Haukeland JW, Konopski Z, Linnestad P, Azimy S, Marit Løberg E, Haaland T, Birkeland K, Bjøro K 2005 Abnormal glucose tolerance is a predictor of steatohepatitis and fibrosis in patients with nonalcoholic fatty liver disease. Scand J Gastroenterol 40:1469-1477
17. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults 2001 Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP): Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 285:2486-2497
18. Gerlier D, Thomasset N 1986 Use of MTT colorimetric assay to measure cell activation. J Immunol Methods 94:57-63
19. Mitsuyoshi H, Yasui K, Harano Y, Endo M, Tsuji K, Minami M, Itoh Y, Okanoue T, Yoshikawa T 2009 Analysis of hepatic genes involved in the metabolism of fatty acids and iron in nonalcoholic fatty liver disease. Hepatol Res 39:366-373
20. Canbay A, Friedman S, Gores GJ 2004 Apoptosis: the nexus of liver injury and fibrosis. Hepatology 39:273-278
21. Aller R, de Luis DA, Izaola O, Sagrado MG, Conde R, Velasco MC, Alvarez T, Pacheco D, Gonzälez JM 2009 Influence of visfatin on histopathological changes of non-alcoholic fatty liver disease. Dig Dis Sci 54:1772-1777
22. Jarrar MH, Baranova A, Collantes R, Ranard B, Stepanova M, Bennett C, Fang Y, Elariny H, Goodman Z, Chandhoke V, Younossi ZM2008 Adipokines and cytokines in non-alcoholic fatty liver disease. Aliment Pharmacol Ther 27:412-421
23. Moschen AR, Molnar C, Wolf AM, Weiss H, Graziadei I, Kaser S, Ebenbichler CF, Stadlmann S, Moser PL, Tilg H 2009 Effects of weight loss induced by bariatric surgery on hepatic adipocytokine expression. J Hepatol 51:765-777
24. de Boer JF, Bahr MJ, Boker KH, Manns MP, Tietge UJ 2009 Plasma levels of PBEF/Nampt/visfatin are decreased in patients with liver cirrhosis. Am J Physiol Gastrointest Liver Physiol 296:G196-G201
25. Kukla M, Zwirska-Korczala K, Gabriel A, Waluga M, Warakomska I, Berdowska A, Rybus-Kalinowska B, Kalinowski M, Janczewska-Kazek E, Wozniak-Grygiel E, Kryczka W 13 October 2009 Visfatin serum levels in chronic hepatitis C patients 2. J Viral Hepat 10.1111/j.1365-2893.2009.01174.x
26. Varma V, Yao-Borengasser A, Rasouli N, Bodles AM, Phanavanh B, Lee MJ, Starks T, Kern LM, Spencer 3rd HJ, McGehee Jr RE, Fried SK, Kern PA 2007 Human visfatin expression: relationship to insulin sensitivity, intramyocellular lipids, and inflammation. J Clin Endocrinol Metab 92:666-672
27. Rongvaux A, Shea RJ, Mulks MH, Gigot D, Urbain J, Leo O, Andris F 2002 Pre-B-cell colony-enhancing factor, whose expression is upregulated in activated lymphocytes, is a nicotinamide phosphoribosyltransferase, a cytosolic enzyme involved in NAD biosynthesis. Eur J Immunol 32:3225-3234
28. Garten A, Petzold S, Barnikol-Oettler A, Körner A, Thasler WE, Kratzsch J, Kiess W, Gebhardt R 2010 Nicotinamide phosphoribosyltransferase (NAMPT/PBEF/visfatin) is constitutively released from human hepatocytes 1. Biochem Biophys Res Commun 391:376-381
29. Nowell MA, Richards PJ, Fielding CA, Ognjanovic S, Topley N, Williams AS, Bryant-Greenwood G, Jones SA 2006 Regulation of pre-B cell colony-enhancing factor by STAT-3-dependent interleukin-6 trans-signaling: implications in the pathogenesis of rheumatoid arthritis. Arthritis Rheum 54:2084-2095
30. Körner A, Garten A, Blüher M, Tauscher R, Kratzsch J, Kiess W 2007 Molecular characteristics of serum visfatin and differential detection by immunoassays 5. J Clin Endocrinol Metab 92:4783-4791
31. Choi KC, Ryu OH, Lee KW, Kim HY, Seo JA, Kim SG, Kim NH, Choi DS, Baik SH, Choi KM 2005 Effect of PPAR-α and -γ agonist on the expression of visfatin, adiponectin, and TNF-α in visceral fat of OLETF rats. Biochem Biophys Res Commun 336:747-753
32. Choi KC, Lee SY, Yoo HJ, Ryu OH, Lee KW, Kim SM, Baik SH, Choi KM 2007 Effect of PPAR-δ agonist on the expression of visfatin, adiponectin, and resistin in rat adipose tissue and 3T3-L1 adipocytes. Biochem Biophys Res Commun 357:62-67
33. Storka A, Vojtassakova E, Mueller M, Kapiotis S, Haider DG, Jungbauer A, Wolzt M 2008 Angiotensin inhibition stimulates PPARγ and the release of visfatin. Eur J Clin Invest 38:820-826
34. Wong VW, Wong GL, Tsang SW, Hui AY, Chan AW, Choi PC, Chim AM, Chu S, Chan FK, Sung JJ, Chan HL 2009 Metabolic and histological features of non-alcoholic fatty liver disease patients with different serum alanine aminotransferase levels. Aliment Pharmacol Ther 29:387-396
35. + metabolism in health and disease. Trends Biochem Sci 32:12-19
36. Rongvaux A, Galli M, Denanglaire S, Van Gool F, Drèze PL, Szpirer C, Bureau F, Andris F, Leo O 2008 Nicotinamide phosphoribosyl transferase/pre-B cell colony-enhancing factor/visfatin is required for lymphocyte development and cellular resistance to genotoxic stress. J Immunol 181:4685-4695
37. Li Y, Zhang Y, Dorweiler B, Cui D, Wang T, Woo CW, Brunkan CS, Wolberger C, Imai S, Tabas I 2008 Extracellular Nampt promotes macrophage survival via a nonenzymatic interleukin-6/STAT3 signaling mechanism. J Biol Chem 283:34833-34843
38. +-dependent protein deacetylase activity and promotes vascular smooth muscle cell maturation. Circ Res 97:25-34
39. Revollo JR, Grimm AA, Imai S 2007 The regulation of nicotinamide adenine dinucleotide biosynthesis by Nampt/PBEF/visfatin in mammals. Curr Opin Gastroenterol 23:164-170
40. +-sirtuin-1-dependent pathway. Nat Med 15:151-158